Article

Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities

2021-10-20

Abstract excerpt

Breakthrough COVID-19 may occur in fully vaccinated persons. In this cohort of 1395 persons (mean age, 54.3 years; 60% female; median body mass index, 30.7) who developed breakthrough COVID-19, there were 107 (7.7%) who required hospitalization by day 28. Hospitalization was significantly associated with the number of medical comorbidities. Anti-spike monoclonal antibody treatment was significantly associated with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9202f45c-f107-5217-ba46-46ba24ae417e
DOI: 10.1101/2021.10.19.21265222

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk ComorbiditiesDOI 10.1101/2021.10.19.21265222Read

Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity Read

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbiditiesSemantic proximity Read

Fully Vaccinated and Boosted Patients Requiring Hospitalization for COVID-19: an Observational Cohort AnalysisSemantic proximity Read

Real World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 OutpatientsSemantic proximity Read

Long Covid after Breakthrough COVID-19: the post-acute sequelae of breakthrough COVID-19Semantic proximity Read

Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions.Semantic proximity Read

Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort studySemantic proximity Read

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELYSemantic proximity Read

Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsSemantic proximity Read

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Semantic proximity Read

Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19Semantic proximity Read